| 000 | 02913nam a22004215i 4500 | ||
|---|---|---|---|
| 999 |
_c392350 _d392350 |
||
| 001 | 392350 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230930175245.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100301s1996 xxu| fo |||| 0|eng d | ||
| 020 | _a9781592595853 | ||
| 024 | 7 |
_a10.1385/0896033058 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 |
_aRM666.A564 _b1996 EB |
||
| 245 | 0 | 0 |
_aAntisense Therapeutics _cedited by Sudhir Agrawal. |
| 250 | _a1st edition 1996 | ||
| 264 | 1 |
_aTotowa, NJ _bHumana Press _c1996 |
|
| 300 | _a1 recurso en línea (XIII, 277 páginas) | ||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 490 | 0 |
_aMethods in Molecular Medicine _x1940-6037 _v1 |
|
| 505 | 0 | _aHistory of Antisense Oligonucleotides -- Pharmacology of Antisense Therapeutic Agents -- Antisense Efficacy -- Antisense Blockade of Expression -- Antisense Tumor Therapy -- Antisense Inhibition of Protein Synthesis and Function -- c-Myb in Smooth Muscle Cells -- Antisense Therapy of Hepatitis B Virus Infection -- Antisense-Mediated Inhibition of Protein Synthesis -- Antisense rel A in Cancer -- Continuous Infusion of Antisense Phosphorothioate Therapeutics -- Protein Kinase-A Directed Antisense Therapy of Tumor Growth In Vivo -- Antisense Therapeutics in the Central Nervous System -- Comparative Pharmacokinetics of Antisense Oligonucleotides. | |
| 520 | _aLeading researchers offer an authoritative survey and analysis of the latest findings on the rapid development of antisense oligonucleotides therapeutic and their application in various in vivo model systems. The book's high-profile contributors provide timely accounts of their state-of-the-art strategies, discussing such topics as the synthesis and purification of oligonucleotides, their selection for a particular gene target, different methods of administration, and the use of various cell lines and cell culture systems. They also examine questions of cellular uptake, in vitro biological activity, in vivo biological activity, the pharmacology and pharmacokinetics of oligonucleotides, and the application of oligonucleotides to the central nervous system. | ||
| 988 | _aSpringer_Protocols_1996 | ||
| 650 | 7 |
_2embne _9140525 _aÁcidos nucleicos |
|
| 650 | 7 |
_2embne _9137893 _aFarmacología _vManuales de laboratorio |
|
| 650 | 7 |
_2embne _9144940 _aARN |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9781489940841 |
| 776 | 0 | 8 |
_iPrinted edition: _z9780896033054 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781489940834 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1385/0896033058 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b09/2023 _dz _ean _zSI |
||